Prot #VLS-101-0003/MK-2140-002: A Phase 2 Study of VLS-101 in Patients with Solid Tumors

Project: Research project

Project Details

StatusActive
Effective start/end date3/1/23 → 3/1/26

Funding

  • Merck Sharp & Dohme LLC (Prot #VLS-101-0003/MK-2140-002)